RECENT NEWS: Tesu Health has been awarded a grant by The Scientific and Technological Research Council of Turkey. Read more…
Digital therapeutics (DTx) are focused on managing specific health conditions using various approaches such as behavior modification
In conditions where they have been investigated, including diabetes, heart disease, and hypertension, DTx have the potential to supplement or even replace traditional prescription medications
Professional support, such as physician supervision and remote learning, improves the quality of behavioral change and helps people sustain healthy behaviors for life
We are a company on the cutting edge of medical technology. We believe that software is going to change the way that medicine is practiced, the way that chronic diseases are managed, and that we can use it to treat diseases caused by behaviors. We develop evidence-based, clinically validated software that can reverse the progression of diseases and improve quality of life for patients.
A prescription digital therapeutic for the treatment of prediabetes. Phase: Pilot
A prescription digital therapeutic for the treatment of obesity. Phase: Prototyping
A prescription digital therapeutic for the treatment of polycystic ovary syndrome. Phase: Preclinical Research
A prescription digital therapeutic for the treatment of gestational diabetes. Phase: Discovery
A prescription digital therapeutic for the treatment of metabolic syndrome. Phase: Discovery
Qualified, comprehensive online education help patients improve and maintain the highest standards of their health
Webinars will be announced soon…
Co-Founder/Business Lead
Co-Founder/Technology Lead
Co-Founder/Medical Lead
